drugset / Trial / NCT04112823

Dexamethasone for Migraine - Dose Comparison

NCT04112823

Phase 4 Completed 209 enrolled Montefiore Medical Center
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Dexamethasone is an evidence-based treatment of acute migraine. This is a randomized comparison of two different doses of dexamethasone for acute migraine. All patients will also be treated with metoclopramide.

Timeline

Start
2019-12-22
Primary completion
2022-12-31
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexamethasone Small molecule 4 mg Intravenous
Comparator Dexamethasone Small molecule 16 mg Intravenous
Comparator Metoclopramide Small molecule 10 mg Intravenous

Indications